对会计师事务所 2024 年度履行监督职责情况报告 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准 则》《国有企业、上市公司选聘会计师事务所管理办法》等规定和要求，深圳瑞 华泰薄膜科技股份有限公司（以下简称"公司"）董事会审计委员会本着勤勉尽 责的原则，恪尽职守，认真履职。现将公司董事会审计委员会对大信会计师事务 所（特殊普通合伙）（以下简称"大信所"）2024 年度履行监督职责的情况汇报 如下： 深圳瑞华泰薄膜科技股份有限公司董事会审计委员会 一、2024 年年审会计师事务所基本情况 （一）会计师事务所基本情况 大信所成立于 1985 年，2012 年 3 月转制为特殊普通合伙制事务所，总部位 于北京，注册地址为北京市海淀区知春路 1 号 22 层 2206。首席合伙人为谢泽敏 先生。截至 2024 年 12 月 31 日，大信从业人员总数 3,957 人，其中合伙人 175 人，注册会计师 1,031 人。注册会计师中，超过 500 人签署过证券服务业务审计 报告。2023 年度业务收入 15.89 亿元，为超过 10,000 家公司提供服务。业务收 入中，审计业务收入 13.80 ...

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2025-009 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 关于董事会换届选举的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"）第二届董事会任期 已届满，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上海 证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等法律法规、规 范性文件以及《深圳瑞华泰薄膜科技股份有限公司公司章程》（以下简称"《公 司章程》"）等规定，公司开展董事会换届选举工作。现将相关情况公告如下： 一、董事会换届选举情况 2025 年 3 月 20 日，公司召开第二届董事会第二十七次会议，审议通过了《关 于公司董事会换届选举暨提名第三届董事会非独立董事候选人的议案》及《关于 公司董事会换届选举暨提名第三届董事会独立董事候选人的议案》。经公司股东 提名并经提名委员会资格审核通过， ...

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2025-012 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 2024 年年度募集资金存放及使用情况专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管 要求》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 和《上海证券交易所科创板股票上市规则》等有关规定，深圳瑞华泰薄膜科技 股份有限公司（以下简称"公司"或"深圳瑞华泰"）2024 年年度募集资金存 放与使用情况说明如下： 一、募集资金基本情况 (一)实际募集资金金额和资金到账时间 根据中国证券监督管理委员会出具的《关于同意深圳瑞华泰薄膜科技股份 有限公司向不特定对象发行可转换公司债券注册的批复》（证监许可〔2022〕 1546 号），公司向不特定对象发行可转换公司债券（以下简称"可转债"）430 万张，每张面值为人民币 10 ...

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2025-017 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 股东大会召开日期：2025年4月11日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间和地点 召开日期时间：2025 年 4 月 11 日 14 点 00 分 召开地点：深圳市宝安区松岗街道办华美工业园深圳瑞华泰薄膜科技股份有 限公司会议室 （五） 网络投票的系统、起止日期和投票时间。 深圳瑞华泰薄膜科技股份有限公司 关于召开 2024 年年度股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东大会类型和届次 2024 年年度股东大会 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自 20 ...

| | | 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 深圳瑞华泰薄膜科技股份有限公司 第二届监事会第十八次会议决议公告 经与会监事充分讨论，本次会议以记名投票方式审议通过了如下议案： （一） 审议通过《关于公司 2024 年度监事会工作报告的议案》 公司监事会认为：2024 年，公司监事会按照《公司法》《中华人民共和国证 券法》《上海证券交易所科创板股票上市规则》等法律、法规及规范性文件，并 依照《公司章程》和公司《监事会议事规则》的规定，认真、独立地履行监督检 查职责。围绕公司合规运营、财务状况及董事和高级管理人员职责履行等方面积 极开展相关工作，为公司的规范运作和健康发展提供了有力保障。 深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"）第二届监事会第十 八次会议于 2025 年 3 月 10 日以电子邮件方式发出了本次会议的召开通知，于 2025 年 3 月 20 日以现场方式召开。本次会议应出席的监事 3 名，实际出席的监 事 3 名。会议的召集、召开和表决程序符合《中华人民共和国公司 ...

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2025-007 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 第二届董事会第二十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"）第二届董事会第二 十七次会议于 2025 年 3 月 10 日以电子邮件方式发出了本次会议的召开通知，于 2025 年 3 月 20 日以现场及通讯方式召开。本次会议应出席的董事 7 名，实际出 席的董事 7 名。会议的召集、召开和表决程序符合《中华人民共和国公司法》（以 下简称"《公司法》"）等法律、行政法规、规范性文件以及《深圳瑞华泰薄膜科 技股份有限公司章程》（以下简称"《公司章程》"）等规定。 二、董事会会议审议情况 经与会董事充分讨论，本次会议以记名投票方式审议通过了如下议案： （一） 审议通过《关于公司 2024 年度董事会工作报告的议案》 ...

Financial Performance - The company reported no cash dividends, stock bonuses, or capital reserve transfers for the 2024 profit distribution plan, which was approved by the board[7]. - The company has not achieved profitability since its listing, indicating ongoing financial challenges[5]. - A standard unqualified audit report was issued by DaXin Accounting Firm, ensuring the accuracy of the financial statements[6]. - The company's operating revenue for 2024 reached RMB 339,054,434.45, representing a 22.88% increase compared to RMB 275,928,076.04 in 2023[22]. - The net profit attributable to shareholders of the listed company was a loss of RMB 57,274,907.69 in 2024, compared to a loss of RMB 19,603,013.62 in 2023[22]. - The net cash flow from operating activities increased significantly by 125.20% to RMB 137,523,874.31 in 2024, up from RMB 61,066,979.78 in 2023[22]. - Total assets as of the end of 2024 amounted to RMB 2,563,947,151.17, reflecting a 4.76% increase from RMB 2,447,368,795.73 at the end of 2023[22]. - The net assets attributable to shareholders decreased by 5.63% to RMB 943,121,144.92 at the end of 2024, down from RMB 999,364,018.07 at the end of 2023[22]. - The company reported a revenue of RMB 336,914,126.10 after excluding non-main business income, which is a 22.10% increase from the previous year[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of RMB 57,628,224.39 in 2024, compared to a loss of RMB 21,888,027.48 in 2023[22]. - The basic and diluted earnings per share for 2024 are both -0.32 CNY, a decrease from -0.11 CNY in 2023[23]. - The net profit attributable to shareholders for the reporting period is -57.27 million CNY, an increase in loss of 37.67 million CNY compared to the previous year[24]. - The weighted average return on equity decreased by 3.97 percentage points to -5.90% in 2024 from -1.93% in 2023[23]. - The gross profit margin decreased, and the increase in depreciation and interest expenses contributed to the losses[93]. Operational Risks and Compliance - The company has detailed various operational risks in the report, which investors should be aware of[5]. - There are no non-operational fund occupations by controlling shareholders or related parties, ensuring financial integrity[9]. - The company has not violated decision-making procedures for external guarantees, maintaining compliance with regulations[10]. - The report includes a forward-looking statement risk declaration, cautioning investors about potential uncertainties in future plans[8]. - The company operates in a competitive market with larger international players, which may affect its market share and operational performance if competition intensifies[100]. - The company does not have a controlling shareholder, which may lead to decision-making challenges and potential risks in business operations[102]. - The company is exposed to risks related to the repayment of convertible bonds if its financial condition deteriorates or if external financing becomes restricted[105]. Research and Development - The company is focusing on the development of new products and technologies in the polyimide film sector, particularly for flexible OLED displays[17]. - The company plans to expand its market presence and explore potential mergers and acquisitions to enhance growth opportunities[17]. - The management remains optimistic about future performance despite the current financial losses, aiming for improved profitability in the upcoming fiscal periods[17]. - Research and development expenses accounted for 9.95% of operating revenue, down from 11.67% in 2023[23]. - The company achieved a total R&D investment of ¥33,733,042.13, representing a 4.78% increase compared to the previous year[72]. - The company obtained 4 new patents during the reporting period, bringing the total to 37 patents, including 30 invention patents[70]. - The company is currently developing a high-performance PI film with a target thickness of 100μm and a thermal conductivity of over 1500W/m.K[75]. - The company is researching high thermal conductivity PI films, targeting a thermal conductivity greater than 0.6W/mK to meet increasing demands in semiconductor packaging[76]. - The company has a total of 11 ongoing R&D projects, focusing on various applications including flexible electronics and high-frequency communication[75]. Market and Product Development - The company is focusing on expanding markets for 5G/6G PI films, electronic substrates, and high thermal conductivity PI films[40]. - The company has entered the supply chains of well-known manufacturers such as Shengyi Technology and Unimicron, indicating strong market acceptance of its electronic PI films[46]. - The flexible display CPI film, with a foldability exceeding 200,000 times, is in the testing phase for terminal brand manufacturers, aiming to fill a domestic gap in flexible display applications[50]. - The company is committed to advancing technology and product development in the clean energy sector, particularly for applications in electric vehicles and wind energy[161]. - The company plans to focus on the development of new products for high-frequency and high-speed flexible electronic substrates in response to the accelerating 6G technology research and AI computing demand[158]. - New product launches include low-dielectric substrates for 5G/6G, high thermal conductivity PI films, and functional PI products for electric vehicles and OLED applications[163]. Governance and Management - The company has a comprehensive governance structure in place, with all board members present at the meeting[6]. - The financial report is signed and sealed by the company's legal representative and accounting personnel, affirming its authenticity[10]. - The company emphasizes the importance of maintaining a robust governance structure to ensure compliance with legal and regulatory requirements, enhancing decision-making fairness[167]. - The company held two shareholder meetings during the reporting period, with all resolutions passed and no resolutions rejected[169]. - The company’s governance structure remains compliant with relevant laws and regulations, ensuring the legality and effectiveness of shareholder meetings[169]. - The company is in the process of preparing for the nomination of new candidates for the board and supervisory positions, indicating a focus on future leadership continuity[176]. - The total remuneration for the chairman, Song Shuqing, was reported as 0.00 million, while the general manager, Tang Changdan, received 77.38 million[173]. - The company has maintained a stable leadership structure with no significant turnover among key executives during the reporting period[181]. Financial Strategy and Investments - The company plans to increase its production capacity of high-performance PI films by 1,600 tons, which is a significant increase compared to existing capacity[104]. - The company plans to implement a profit distribution proposal for 2023, reflecting a commitment to shareholder returns[189]. - The company will adopt a mixed financing strategy to support large-scale project investments while monitoring long-term government bond opportunities to reduce financial costs[165]. - The company is strategically positioning itself in upstream specialty monomers to ensure timely supply of raw materials and mitigate supply chain risks[165]. - The company has invested a total of 5,956.62 million RMB in the reporting period, representing a 42.09% increase compared to the previous year[149]. - The company reported a total revenue of 1.2 billion RMB for the fiscal year 2024, representing a year-over-year growth of 15%[179]. - The company has provided a revenue guidance of 1.5 billion RMB for the next fiscal year, which reflects an expected growth of 25%[179]. - The company plans to invest in high-speed communication flexible substrates and functional polyimide films for rail transit through its wholly-owned subsidiary[164].

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2025-013 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 关于 2024 年度利润分配预案的公告 经大信会计师事务所（特殊普通合伙）审计，2024 年度公司合并口径实现 归属于公司普通股股东净利润为人民币-5,727.49 万元，截至 2024 年 12 月 31 日， 母公司期末可供分配利润为人民币 11,267.62 万元。 根据《中华人民共和国公司法》《深圳瑞华泰薄膜科技股份有限公司章程》 的相关规定，鉴于公司 2024 年度亏损，结合公司实际经营和长期资金发展需求， 为实现公司平稳运营、健康发展，同时更好地维护全体股东的长远利益，公司 2024 年度不派发现金红利，不进行资本公积转增股本，不送红股。 本次利润分配方案尚需提交公司股东大会审议。 二、公司履行的决策程序 1 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 深圳瑞华泰薄膜科技股份有 ...

Financial Performance - The total operating revenue for 2024 reached CNY 339.05 million, representing a year-on-year increase of 22.88%[3] - The net profit attributable to the parent company was CNY -57.27 million, an increase in loss of CNY 37.67 million compared to the previous year[6] - The net profit attributable to the parent company after deducting non-recurring gains and losses was CNY -57.67 million, an increase in loss of CNY 35.78 million year-on-year[6] - The basic earnings per share were CNY -0.32, a decline compared to CNY -0.11 in the previous year[3] - The weighted average return on net assets was -5.90%, a decrease of 3.97 percentage points from the previous year[3] Assets and Equity - Total assets at the end of the reporting period were CNY 2,563.95 million, an increase of 4.76% from the beginning of the period[6] - Equity attributable to the parent company decreased by 5.63% to CNY 943.12 million compared to the beginning of the period[6] Operational Challenges - The company faced pressure on short-term performance due to global economic recovery challenges and intensified competition[6] - Management expenses and financial expenses increased by 28.38% and 137.03% respectively due to depreciation and interest expenses from the new production project[7] Strategic Focus - The company is focusing on high-performance polyimide film R&D, production, and sales while adjusting product structure and expanding new product application markets[6]

国信证券股份有限公司（以下简称"国信证券"或"保荐机构"）作为深圳 瑞华泰薄膜科技股份有限公司（以下简称"瑞华泰"或"公司"）首次公开发行 股票和向不特定对象发行可转换公司债券的保荐机构，根据《上海证券交易所科 创板股票上市规则》《上海证券交易所上市公司自律监管指引第 11 号——持续 督导》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等 有关法律、法规和规范性文件的要求，对瑞华泰自 2024 年 1 月 1 日至本次现场 检查期间（以下简称"检查期"）的规范运作情况进行了现场检查，就现场检查 的有关情况报告如下： 一、本次现场检查的基本情况 国信证券股份有限公司 关于深圳瑞华泰薄膜科技股份有限公司 2024 年度持续督导工作现场检查报告 上海证券交易所： 2025 年 2 月 5 日至 2 月 6 日，国信证券现场检查人员郭振国通过查阅资料、 实地调研等方式对瑞华泰检查期的有关情况进行了现场检查，检查的内容包括： （一）公司治理和内部控制情况；（二）信息披露情况；（三）公司的独立性以 及与主要股东及其他关联方资金往来情况；（四）募集资金使用情况；（五）关 联交易、对外担保、重大对外投资 ...